Trxade health, Inc files its 3Q 10Q
TAMPA, FL, Jan. 17, 2024 (GLOBE NEWSWIRE) — TRxADE HEALTH, INC. (NASDAQ:MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, announced today that it filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”).
Related news for (MEDS)
- trxade health, inc. announces name change to scienture holdings, inc. and ticker symbol change to “scnx”
- trxade health, inc. announces name change to scienture holdings, inc.
- TRxADE Health and Scienture to close Business Combination Transaction Valued at $103 Million
- Daily Report Card 6 March 2024
- TRxADE Health to Pay Special Cash Dividend